Hybrid natural orifice transluminal endoscopic surgery in gastric subepithelial tumors

Table 1 The published studies on hybrid natural orifice transluminal endoscopic surgery of gastric subepithelial tumors

Author, year and number of patients	Operation time, min	Intraoperative bleeding, mL	Tumor size, mm	Number of linear staplers used	Postoperative complications	Hospital stay, d	Tumor location	Type of growth	Pathologic diagnosis, n
Hiki et al[20], n = 7	169.0 ± 17.0	7.0 ± 2.0	46.0 ± 3.0 (35-60)	2.2 ± 0.1	0	7.4 ± 8.1	U4M1L1Remnant stomach, posterior 1	Extragastric type 1Intragastric type 6	GIST, 6Schwannoma, 1
Tsujimoto et al[21], n = 20	157.5 ± 68.4 (89-316)	3.5 ± 6.4 (0-20)	37.9 ± 11.0 (18-63)	2.7 ± 0.5 (2-3)	0	11.6 ± 9.5 (6-13)	U8 (40%)M8 (40%)L4 (20%)	Extragastric type 2 (15%)Intragastric type 17 (85%)	GIST, 16 (80%)Inflammation for parasite, 1 (5%), leiomyoma, 1 (5%),glomus tumor, 1 (5%), aberrant pancreas, 1 (5%)
Abe et al[22], n = 4	221.5 ± 129.4	38.0 ± 46.7	38.0 ± 7.1 (22-43)	NA	0	7.5 ± 0.7	U1M3	NA	GIST, 1Lipoma, 1Ectopic pancreas, 1Schwannoma, 1

Data are expressed as median ± SD (range). U: Upper portion; M: Middle portion; L: Lower portion; NA: Not available; GIST: Gastrointestinal tumor.